BridgeBio(BBIO) - 2025 Q3 - Earnings Call Transcript

BridgeBio Pharma (NasdaqGS:BBIO) Q3 2025 Earnings Call October 29, 2025 04:30 PM ET Company ParticipantsAndrew Tsai - SVPMatt Outten - COODanielle Brill - Managing DirectorChinmay Shukla - SVP Strategic FinanceThomas Trimarchi - CFO and PresidentRyan McElroy - Biotechnology Equity Research AssociateNeil Kumar - CEO and FounderTom Trimarchi - President and CFOJason Zemansky - VPConference Call ParticipantsSalim Syed - Managing Director and Senior Biotechnology AnalystAnupam Rama - Managing Director and Senio ...